Imbruvica and Back Pain: What Users Say
Reviews for Imbruvica
- Mfi...
- January 9, 2018
For Graft Versus Host Disease "About me: AML, stem cell transplant survivor with GVHD. How Imbruvica helped: I started Imbruvica in 4/17. Prior to taking it, I was completely debilitated. After 4 full months on the drug, I noted marked improvement. Now I am able to walk, light lifting, and carry out regular activity with much less fatigue and pain. My skin GVHD is not showing any symptoms. It's been a godsend! Side effects: I noticed cramping at about 5 months and back and joint pain at 8 months. The cramping became severe, however, it is managed well with tonic water. The pain is extreme at times - but so far outweighs the GVHD symptoms."
- Nic...
- January 24, 2017
For Chronic Lymphocytic Leukemia "My 78-year-old mother was taking this, and in her third month she had vomiting one day, back and neck pain for 3 days, then passed away in her sleep. Didn't get a chance to lower the dose."
Frequently asked questions
- How long can you stay on Imbruvica (ibrutinib)?
- How much does Imbruvica cost?
- How quickly does Imbruvica (ibrutinib) work?
- Does ibrutinib cause hair loss?
See also:
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Kesimpta
Kesimpta is used to treat relapsing forms of multiple sclerosis (MS), including clinically isolated ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Calquence
Calquence (acalabrutinib) is used to treat chronic lymphocytic leukemia (CLL), and mantle cell ...
Brukinsa
Brukinsa is used to treat adults with mantle cell lymphoma, Waldenström’s macroglobulinemia, ma ...
Venclexta
Venclexta may be used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma ...
Zanubrutinib
Zanubrutinib is a targeted treatment that may be used to treat adults with chronic lymphocytic ...
Acalabrutinib
Acalabrutinib (Calquence) is used to treat chronic lymphocytic leukemia (CLL), and mantle cell ...
Venetoclax
Venetoclax (brand name Venclexta) may be used to treat CLL, SLL, or AML in those aged 75 years or ...
Are you taking this medicine?
Your review helps others make informed decisions.More about Imbruvica (ibrutinib)
- Imbruvica consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (69)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: BTK inhibitors
- Breastfeeding
- En español
For Chronic Lymphocytic Leukemia "I started Imbruvica in August 2019. I had to stop after only one dose due to an ER visit showing an infection. I was taking 420 mg. Started back on Imbruvica again, lasted 7 doses, then another infection, this time a UTI that made me septic. I stayed out of ICU. Went on antibiotics, cleared up the infection, and was started again on Imbruvica at 280 mg. I have been 28 days. I have nausea, some diarrhea, and pain in my lower right quadrant, and both sides of my lower back. I have medication to help with the nausea and diarrhea. This medicine is my best chance to get my CLL back into remission. I was on Bendamustine, Rituxan, and Neulasta. I was allergic to all three, had 7 hospitalizations, and almost died. I was in remission for 39 months before this spring CLL's ugly head appeared in my life again."